The Science Behind
the Protocol.
Nicotinamide is one of the most rigorously studied molecules in dermatology and longevity research.
What Changes at the Cellular Level.
NAD+ is a required cofactor for PARP enzymes — responsible for detecting and repairing UV-induced DNA strand breaks in skin cells.
NAD+ is essential to the electron transport chain, increasing mitochondrial efficiency and cellular energy output.
Sirtuins are NAD+-dependent enzymes regulating cellular stress response, inflammation, and longevity-associated gene expression.
Nicotinamide increases ceramide synthesis in the stratum corneum — protecting against irritants and moisture loss.
Inhibits inflammatory cytokine production in UV-exposed skin, reducing the cascade that accelerates visible photoageing.
Emerging research links NAD+-dependent sirtuins to telomere length — a key biological marker of cellular ageing.
What the Research Shows.
500mg twice daily demonstrated a 23% reduction in new non-melanoma skin cancers versus placebo in high-risk patients over 12 months.
Oral 500mg demonstrated superior dermal tissue penetration versus topical, with measurable NAD+ precursor increases within 8 weeks.
Significant reductions in inflammatory ageing biomarkers and improvements in reported energy levels over a 24-week trial period.
Summaries for educational context only. Kiveton Pharmacy makes no medicinal claims. Individual results vary. Not intended to diagnose, treat, cure, or prevent any disease.
clinical protocol?
Conditions Nicotinamide
May Help With.
The following areas have clinical or peer-reviewed evidence supporting a role for oral Nicotinamide 500mg. Our Pharmacist reviews each consultation individually to confirm suitability.


